The novel L-nucleoside analogue, 5-Fluorotroxacitabine, displays potent efficacy against acute myeloid leukemia
Open Access
- 19 December 2019
- journal article
- letter
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 106 (2) , 574-579
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Cytidine deaminase polymorphisms and worse treatment response in normal karyotype AMLJournal of Human Genetics, 2015
- Development of New Deoxycytidine Kinase Inhibitors and Noninvasive in Vivo Evaluation Using Positron Emission TomographyJournal of Medicinal Chemistry, 2013
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNetBlood, 2010
- Clonogenic assay of cells in vitroNature Protocols, 2006
- Potential mechanisms of resistance to cytarabine in AML patientsLeukemia Research, 2002
- High incidence of alternatively spliced forms of deoxycytidine kinase in patients with resistant acute myeloid leukemia.2000
- High incidence of alternatively spliced forms of deoxycytidine kinase in patients with resistant acute myeloid leukemiaBlood, 2000
- Common resistance mechanisms to deoxynucleoside analogues in variants of the human erythroleukaemic line K562British Journal of Haematology, 1999
- Structural and functional analysis of the cytidine deaminase gene in patients with acute myeloid leukaemiaBritish Journal of Haematology, 1998
- A three-dimensional model to analyze drug-drug interactionsAntiviral Research, 1990